OTCMKTS:TKPYY - Takeda Pharmaceutical Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$17.00
▼ -0.22 (-1.28%)

This chart shows the closing price for TKPYY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Takeda Pharmaceutical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TKPYY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TKPYY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Takeda Pharmaceutical in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $17.00.

This chart shows the closing price for TKPYY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in Takeda Pharmaceutical. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/31/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/29/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/27/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/26/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/22/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
1/31/2017Canaccord GenuityReiterated RatingBuy
1/25/2017Canaccord GenuityReiterated RatingBuy
10/21/2016UBS GroupUpgradeNeutral ➝ Buy
(Data available from 9/23/2016 forward)

News Sentiment Rating

-0.14 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/25/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/27/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/26/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/26/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/25/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/25/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/24/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/23/2021

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Takeda Pharmaceutical logo
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
Read More

Today's Range

Now: $17.00
Low: $16.98
High: $17.19

50 Day Range

MA: $16.80
Low: $16.30
High: $17.26

52 Week Range

Now: $17.00
Low: $15.50
High: $31.29

Volume

1,503,214 shs

Average Volume

979,605 shs

Market Capitalization

$26.56 billion

P/E Ratio

12.11

Dividend Yield

3.44%

Beta

0.42

Frequently Asked Questions

What sell-side analysts currently cover shares of Takeda Pharmaceutical?

The following Wall Street analysts have issued research reports on Takeda Pharmaceutical in the last year:
View the latest analyst ratings for TKPYY.

What is the current price target for Takeda Pharmaceutical?

0 Wall Street analysts have set twelve-month price targets for Takeda Pharmaceutical in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Takeda Pharmaceutical in the next year.
View the latest price targets for TKPYY.

What is the current consensus analyst rating for Takeda Pharmaceutical?

Takeda Pharmaceutical currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for TKPYY.

What other companies compete with Takeda Pharmaceutical?

How do I contact Takeda Pharmaceutical's investor relations team?

Takeda Pharmaceutical's physical mailing address is 1-1 Doshomachi 4-chome Chuo-ku, Osaka M0, 540-8645. The company's listed phone number is (166) 204-2111. The official website for Takeda Pharmaceutical is www.takeda.com.